Restoring facial fullness after GLP-1 weight loss with Radiesse
Part of Skin clinical trials.
This trial tests whether a facial filler called Radiesse can restore volume lost during weight loss from GLP-1 medications (like Wegovy or Mounjaro). It's for adults just starting GLP-1 therapy who expect to lose 20 pounds or more and want to see if fillers can help their face look fuller.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 65 years old.
- You are just starting a GLP-1 medication (like semaglutide or tirzepatide) for weight loss or diabetes weight management and plan to lose at least 20 pounds.
- Your body mass index (BMI) is between 24 and 32.
- You have enough facial fat (your face is not already very hollow) and are willing to get facial filler injections.
- You have not had any facial cosmetic procedures in the last 2 years (like fillers, fat transfer, or lifts) or certain treatments in the last year or 4 months.
- You do not have severe acne, psoriasis, or scars on your face, and you are not allergic to calcium hydroxylapatite (Radiesse) or lidocaine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a hyaluronic acid filler (a gel injected into the skin) can improve skin quality in women who are taking or not taking GLP-1 medications (like Ozempic or Wegovy). It aims to see if the filler helps with skin radiance, elasticity, tone, firmness, fine lines, wrinkles, and smoothness.
This study tests whether injections of poly-L-lactic acid (a collagen-boosting filler) can improve loose skin on the belly in women taking or not taking GLP-1 medications (like Ozempic or Wegovy). It aims to help people who have mild to moderate loose skin and are at a stable weight.
This study tests a new facial serum (AGE Serum) designed to improve signs of aging like fine lines and loose skin in post-menopausal women who are taking GLP-1 medications (like Ozempic or Wegovy). Researchers want to see if it's safe and if it actually works to improve how the skin looks.
This trial tests a hyaluronic acid gel filler to restore lost volume and smooth fine lines in the face. It may help if you have mild-to-moderate aging in your cheeks or around your nose and mouth and have not had other facial treatments recently.
This trial tests whether PLLA injections can safely improve facial sagging in people who lost weight on GLP-1 drugs. If you are between 30 and 60, have noticeable sagging or smile lines, and have not had other facial treatments recently, this may be an option.
This study tests two types of injectable fillers, PLLA and CaHA-R, to improve skin texture and tightness in the cheeks and chest area. It may be a good option for women looking to treat mild to severe skin irregularities.
Hear when a new Volume Loss (Soft Tissue Ptosis or Atrophy ) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.